Page last updated: 2024-09-05

solifenacin succinate and donepezil

solifenacin succinate has been researched along with donepezil in 1 studies

Compound Research Comparison

Studies
(solifenacin succinate)
Trials
(solifenacin succinate)
Recent Studies (post-2010)
(solifenacin succinate)
Studies
(donepezil)
Trials
(donepezil)
Recent Studies (post-2010) (donepezil)
5221943433,1935571,594

Protein Interaction Comparison

ProteinTaxonomysolifenacin succinate (IC50)donepezil (IC50)
AcetylcholinesteraseElectrophorus electricus (electric eel)0.4231
AcetylcholinesteraseTetronarce californica (Pacific electric ray)0.0265
Amyloid-beta precursor proteinHomo sapiens (human)0.022
CholinesteraseHomo sapiens (human)4.5742
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)7.42
Amine oxidase [flavin-containing] BRattus norvegicus (Norway rat)5
Amine oxidase [flavin-containing] A Rattus norvegicus (Norway rat)7.4
AcetylcholinesteraseMus musculus (house mouse)1.5489
AcetylcholinesteraseHomo sapiens (human)0.3257
Acetylcholinesterase Bos taurus (cattle)0.1644
Choline O-acetyltransferase Rattus norvegicus (Norway rat)0.0053
AcetylcholinesteraseRattus norvegicus (Norway rat)0.0182
Beta-secretase 1Homo sapiens (human)0.8666
CholinesteraseEquus caballus (horse)3.7325
CholinesteraseMus musculus (house mouse)1.992
Acetylcholine receptor subunit epsilonHomo sapiens (human)0.0324
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)3.7844
Acyl-CoA:cholesterol acyltransferase Oryctolagus cuniculus (rabbit)0.008
Carboxylic ester hydrolase Rattus norvegicus (Norway rat)4.715
Carboxylic ester hydrolase Equus caballus (horse)4.5551
Histamine H3 receptorHomo sapiens (human)0.35

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chase, TN; Clarence-Smith, K; Farlow, MR1

Trials

1 trial(s) available for solifenacin succinate and donepezil

ArticleYear
Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer's Disease.
    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2017, Volume: 14, Issue:2

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Drug Therapy, Combination; Female; Humans; Indans; Male; Maximum Tolerated Dose; Middle Aged; Muscarinic Antagonists; Piperidines; Single-Blind Method; Solifenacin Succinate; Treatment Outcome

2017